USP: Proposed Addition to Chapter <1236> Solubility Measurements
Recommendation

Thursday, 3 September 2026 9 .00 - 17.00 h
Establishment, Use and Maintenance of Analytical Reference Substances
A new version of the USP general chapter 〈1236〉 Solubility Measurements has been published in the Pharmacopeial Forum, PF 48(2), for public comments.
The draft is based on the version of the chapter official as of December 1, 2020. In addition to the existing text, it is proposed to add the porcine simulated gastric and intestinal fluids in the subchapter on solubility measurements in biorelevant media. Additionally, minor editorial changes have been made.
The proposal can be consulted after registration on the Pharmacopeial Forum website. Comments can be submitted until May 31, 2022.
Related GMP News
08.07.2026Revised Annex 19 on Reference and Retention Samples
01.07.2026Several FDA Warning Letters and Untitled Letters on Asbestos Testing of Talc in OTC Drug Products
24.06.2026Analytical Quality Group Developments January through April 2026
17.06.2026BioPhorum Publishes a Roadmap for QC Sample Test Execution
03.06.2026EMA Provides an Outlook on the Product-Specific Bioequivalence Guidelines Expected in 2026
03.06.2026FDA Warning Letter: Missing Method Validation - From a QC Topic to a Market-Access Problem


